174 related articles for article (PubMed ID: 23192284)
1. HP-β-CD-PLGA nanoparticles improve the penetration and bioavailability of puerarin and enhance the therapeutic effects on brain ischemia-reperfusion injury in rats.
Tao HQ; Meng Q; Li MH; Yu H; Liu MF; Du D; Sun SL; Yang HC; Wang YM; Ye W; Yang LZ; Zhu DL; Jiang CL; Peng HS
Naunyn Schmiedebergs Arch Pharmacol; 2013 Jan; 386(1):61-70. PubMed ID: 23192284
[TBL] [Abstract][Full Text] [Related]
2. Polysorbate 80-coated PLGA nanoparticles improve the permeability of acetylpuerarin and enhance its brain-protective effects in rats.
Sun D; Xue A; Zhang B; Lou H; Shi H; Zhang X
J Pharm Pharmacol; 2015 Dec; 67(12):1650-62. PubMed ID: 26407669
[TBL] [Abstract][Full Text] [Related]
3. Preparation and evaluation of a Carbopol/HPMC-based in situ gelling ophthalmic system for puerarin.
Wu C; Qi H; Chen W; Huang C; Su C; Li W; Hou S
Yakugaku Zasshi; 2007 Jan; 127(1):183-91. PubMed ID: 17202799
[TBL] [Abstract][Full Text] [Related]
4. The comparison of different daidzein-PLGA nanoparticles in increasing its oral bioavailability.
Ma Y; Zhao X; Li J; Shen Q
Int J Nanomedicine; 2012; 7():559-70. PubMed ID: 22346351
[TBL] [Abstract][Full Text] [Related]
5. The permeability of puerarin loaded poly(butylcyanoacrylate) nanoparticles coated with polysorbate 80 on the blood-brain barrier and its protective effect against cerebral ischemia/reperfusion injury.
Zhao LX; Liu AC; Yu SW; Wang ZX; Lin XQ; Zhai GX; Zhang QZ
Biol Pharm Bull; 2013; 36(8):1263-70. PubMed ID: 23902970
[TBL] [Abstract][Full Text] [Related]
6. Effect of a 2-HP-β-Cyclodextrin Formulation on the Biological Transport and Delivery of Chemotherapeutic PLGA Nanoparticles.
Zheng K; Huang Z; Huang J; Liu X; Ban J; Huang X; Luo H; Chen Z; Xie Q; Chen Y; Lu Z
Drug Des Devel Ther; 2021; 15():2605-2618. PubMed ID: 34168432
[TBL] [Abstract][Full Text] [Related]
7. Effect of formulation parameters on 2-methoxyestradiol release from injectable cylindrical poly(DL-lactide-co-glycolide) implants.
Desai KG; Mallery SR; Schwendeman SP
Eur J Pharm Biopharm; 2008 Sep; 70(1):187-98. PubMed ID: 18472254
[TBL] [Abstract][Full Text] [Related]
8. Enhanced oral bioavailability and anticancer efficacy of fisetin by encapsulating as inclusion complex with HPβCD in polymeric nanoparticles.
Kadari A; Gudem S; Kulhari H; Bhandi MM; Borkar RM; Kolapalli VR; Sistla R
Drug Deliv; 2017 Nov; 24(1):224-232. PubMed ID: 28156161
[TBL] [Abstract][Full Text] [Related]
9. Characterisation of 2-HP-β-cyclodextrin-PLGA nanoparticle complexes for potential use as ocular drug delivery vehicles.
Li F; Wen Y; Zhang Y; Zheng K; Ban J; Xie Q; Wen Y; Liu Q; Chen F; Mo Z; Liu L; Chen Y; Lu Z
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):4097-4108. PubMed ID: 31663388
[No Abstract] [Full Text] [Related]
10. PLGA Nanoparticle Platform for Trans-Ocular Barrier to Enhance Drug Delivery: A Comparative Study Based on the Application of Oligosaccharides in the Outer Membrane of Carriers.
Jiang G; Jia H; Qiu J; Mo Z; Wen Y; Zhang Y; Wen Y; Xie Q; Ban J; Lu Z; Chen Y; Wu H; Ni Q; Chen F; Lu J; Wang Z; Li H; Chen J
Int J Nanomedicine; 2020; 15():9373-9387. PubMed ID: 33262593
[TBL] [Abstract][Full Text] [Related]
11. PLGA microparticles encapsulating prostaglandin E1-hydroxypropyl-β-cyclodextrin (PGE1-HPβCD) complex for the treatment of pulmonary arterial hypertension (PAH).
Gupta V; Davis M; Hope-Weeks LJ; Ahsan F
Pharm Res; 2011 Jul; 28(7):1733-49. PubMed ID: 21626061
[TBL] [Abstract][Full Text] [Related]
12.
Zhang L; Yang S; Wong LR; Xie H; Ho PC
Mol Pharm; 2020 Nov; 17(11):4256-4269. PubMed ID: 33084343
[TBL] [Abstract][Full Text] [Related]
13. Targeted delivery of puerarin/glycyrrhetinic acid-PEG-PBLA complex attenuated liver ischemia/reperfusion injury via modulating Toll-like receptor 4/nuclear factor-κB pathway.
Xiao Y; Huang J; Xu J; Zeng L; Tian J; Lou Y; Liu Y; Hu B; Tong F; Shen R
Ther Deliv; 2018 Mar; 9(4):245-255. PubMed ID: 29540127
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics, tissue distribution and relative bioavailability of puerarin solid lipid nanoparticles following oral administration.
Luo CF; Yuan M; Chen MS; Liu SM; Zhu L; Huang BY; Liu XW; Xiong W
Int J Pharm; 2011 May; 410(1-2):138-44. PubMed ID: 21392565
[TBL] [Abstract][Full Text] [Related]
15. Influence of hydrophilic additives on the supersaturation and bioavailability of dutasteride-loaded hydroxypropyl-β-cyclodextrin nanostructures.
Kim MS
Int J Nanomedicine; 2013; 8():2029-39. PubMed ID: 23737668
[TBL] [Abstract][Full Text] [Related]
16. Development of L-carnosine functionalized iron oxide nanoparticles loaded with dexamethasone for simultaneous therapeutic potential of blood brain barrier crossing and ischemic stroke treatment.
Lu X; Zhang Y; Wang L; Li G; Gao J; Wang Y
Drug Deliv; 2021 Dec; 28(1):380-389. PubMed ID: 33586561
[TBL] [Abstract][Full Text] [Related]
17. A Novel Solid Nanocrystals Self-Stabilized Pickering Emulsion Prepared by Spray-Drying with Hydroxypropyl-β-cyclodextrin as Carriers.
Zhang J; Wang Y; Wang J; Yi T
Molecules; 2021 Mar; 26(6):. PubMed ID: 33806952
[TBL] [Abstract][Full Text] [Related]
18. Enhanced bioavailability of orally administered flurbiprofen by combined use of hydroxypropyl-cyclodextrin and poly(alkyl-cyanoacrylate) nanoparticles.
Zhao X; Li W; Luo Q; Zhang X
Eur J Drug Metab Pharmacokinet; 2014 Mar; 39(1):61-7. PubMed ID: 23700219
[TBL] [Abstract][Full Text] [Related]
19. PLGA nanoparticles for the oral delivery of 5-Fluorouracil using high pressure homogenization-emulsification as the preparation method and in vitro/in vivo studies.
Li X; Xu Y; Chen G; Wei P; Ping Q
Drug Dev Ind Pharm; 2008 Jan; 34(1):107-15. PubMed ID: 18214762
[TBL] [Abstract][Full Text] [Related]
20. Brain targeting with surface-modified poly(D,L-lactic-co-glycolic acid) nanoparticles delivered via carotid artery administration.
Tahara K; Miyazaki Y; Kawashima Y; Kreuter J; Yamamoto H
Eur J Pharm Biopharm; 2011 Jan; 77(1):84-8. PubMed ID: 21074612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
